Charles Schwab’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $394M | Buy |
9,223,151
+52,971
| +0.6% | +$2.88M | 0.05% | 286 |
|
|
2026
Q1 | $575M | Buy |
9,170,180
+223,677
| +3% | +$17.9M | 0.09% | 188 |
|
|
2025
Q4 | $853M | Buy |
8,946,503
+104,190
| +1% | +$10.2M | 0.13% | 128 |
|
|
2025
Q3 | $863M | Buy |
8,842,313
+122,402
| +1% | +$12.7M | 0.14% | 125 |
|
|
2025
Q2 | $937M | Buy |
8,719,911
+143,697
| +2% | +$14.5M | 0.16% | 105 |
|
|
2025
Q1 | $865M | Buy |
8,576,214
+101,183
| +1% | +$10.2M | 0.16% | 108 |
|
|
2024
Q4 | $757M | Buy |
8,475,031
+456,654
| +6% | +$40.2M | 0.14% | 122 |
|
|
2024
Q3 | $672M | Buy |
8,018,377
+64,720
| +0.8% | +$5.1M | 0.13% | 136 |
|
|
2024
Q2 | $613M | Buy |
7,953,657
+61,283
| +0.8% | +$4.49M | 0.12% | 148 |
|
|
2024
Q1 | $541M | Buy |
7,892,374
+197,648
| +3% | +$12.7M | 0.12% | 139 |
|
|
2023
Q4 | $445M | Buy |
7,694,726
+51,892
| +0.7% | +$2.77M | 0.11% | 149 |
|
|
2023
Q3 | $404M | Buy |
7,642,834
+201,008
| +3% | +$10.5M | 0.12% | 148 |
|
|
2023
Q2 | $403M | Sell |
7,441,826
-87
| -0% | -$4.54K | 0.11% | 151 |
|
|
2023
Q1 | $372M | Sell |
7,441,913
-73,342
| -1% | -$3.46M | 0.11% | 151 |
|
|
2022
Q4 | $348M | Buy |
7,515,255
+147,478
| +2% | +$6.39M | 0.11% | 164 |
|
|
2022
Q3 | $285M | Sell |
7,367,777
-397,617
| -5% | -$16M | 0.1% | 181 |
|
|
2022
Q2 | $289M | Sell |
7,765,394
-34,661
| -0.4% | -$1.41M | 0.1% | 187 |
|
|
2022
Q1 | $345M | Buy |
7,800,055
+245,797
| +3% | +$10.7M | 0.1% | 175 |
|
|
2021
Q4 | $321M | Buy |
7,554,258
+194,378
| +3% | +$8.17M | 0.09% | 187 |
|
|
2021
Q3 | $319M | Buy |
7,359,880
+709,180
| +11% | +$31.4M | 0.1% | 172 |
|
|
2021
Q2 | $284M | Buy |
6,650,700
+165,670
| +3% | +$6.97M | 0.09% | 187 |
|
|
2021
Q1 | $251M | Sell |
6,485,030
-465,971
| -7% | -$17.6M | 0.09% | 192 |
|
|
2020
Q4 | $250M | Buy |
6,951,001
+537,768
| +8% | +$19.4M | 0.1% | 187 |
|
|
2020
Q3 | $245M | Buy |
6,413,233
+150,843
| +2% | +$5.81M | 0.11% | 168 |
|
|
2020
Q2 | $220M | Buy |
6,262,390
+232,804
| +4% | +$8.38M | 0.11% | 179 |
|
|
2020
Q1 | $197M | Buy |
6,029,586
+76,349
| +1% | +$2.98M | 0.12% | 169 |
|
|
2019
Q4 | $269M | Buy |
5,953,237
+117,260
| +2% | +$4.91M | 0.14% | 127 |
|
|
2019
Q3 | $237M | Buy |
5,835,977
+181,062
| +3% | +$7.67M | 0.14% | 136 |
|
|
2019
Q2 | $243M | Buy |
5,654,915
+119,294
| +2% | +$4.59M | 0.15% | 126 |
|
|
2019
Q1 | $212M | Buy |
5,535,621
+81,194
| +1% | +$3.1M | 0.14% | 137 |
|
|
2018
Q4 | $193M | Buy |
5,454,427
+130,886
| +2% | +$4.75M | 0.15% | 124 |
|
|
2018
Q3 | $205M | Buy |
5,323,541
+39,933
| +0.8% | +$1.39M | 0.14% | 135 |
|
|
2018
Q2 | $173M | Buy |
5,283,608
+128,310
| +2% | +$3.87M | 0.13% | 152 |
|
|
2018
Q1 | $141M | Buy |
5,155,298
+246,223
| +5% | +$6.69M | 0.11% | 176 |
|
|
2017
Q4 | $122M | Buy |
4,909,075
+187,773
| +4% | +$5.18M | 0.1% | 197 |
|
|
2017
Q3 | $138M | Buy |
4,721,302
+61,729
| +1% | +$1.7M | 0.12% | 158 |
|
|
2017
Q2 | $129M | Sell |
4,659,573
-634,350
| -12% | -$16.8M | 0.12% | 162 |
|
|
2017
Q1 | $132M | Sell |
5,293,923
-109,612
| -2% | -$2.67M | 0.13% | 145 |
|
|
2016
Q4 | $117M | Buy |
5,403,535
+20,138
| +0.4% | +$439K | 0.13% | 144 |
|
|
2016
Q3 | $128M | Buy |
5,383,397
+1,582,054
| +42% | +$37.7M | 0.15% | 127 |
|
|
2016
Q2 | $88.8M | Buy |
3,801,343
+312,934
| +9% | +$6.77M | 0.11% | 173 |
|
|
2016
Q1 | $65.6M | Buy |
3,488,409
+61,239
| +2% | +$1.08M | 0.09% | 240 |
|
|
2015
Q4 | $63.2M | Sell |
3,427,170
-62,816
| -2% | -$1.13M | 0.09% | 229 |
|
|
2015
Q3 | $57.3M | Sell |
3,489,986
-2,778
| -0.1% | -$47.5K | 0.08% | 236 |
|
|
2015
Q2 | $61.8M | Sell |
3,492,764
-629,363
| -15% | -$11.2M | 0.09% | 231 |
|
|
2015
Q1 | $73.2M | Buy |
4,122,127
+73,372
| +2% | +$1.16M | 0.1% | 194 |
|
|
2014
Q4 | $53.6M | Buy |
4,048,755
+191,642
| +5% | +$2.45M | 0.08% | 243 |
|
|
2014
Q3 | $45.6M | Sell |
3,857,113
-341,930
| -8% | -$4.31M | 0.08% | 249 |
|
|
2014
Q2 | $53.6M | Sell |
4,199,043
-427,138
| -9% | -$5.55M | 0.09% | 216 |
|
|
2014
Q1 | $62.5M | Buy |
4,626,181
+66,620
| +1% | +$874K | 0.11% | 188 |
|
|
2013
Q4 | $54.8M | Sell |
4,559,561
-458,469
| -9% | -$5.42M | 0.1% | 189 |
|
|
2013
Q3 | $59M | Sell |
5,018,030
-56,594
| -1% | -$612K | 0.12% | 172 |
|
|
2013
Q2 | $47.5M | Buy |
+5,074,624
| New | +$43M | 0.11% | 191 |
|
Other funds holding BSX
Charles Schwab's BSX Position: Q2 2026 in Review
Charles Schwab increased its Boston Scientific (BSX) stake by 0.58% in Q2 2026, buying an estimated $2.88M and bringing the position to 9,223,151 shares worth $394M. The position accounts for 0.05% of the portfolio, ranked #286.
Charles Schwab first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $937M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Charles Schwab held 9,223,151 shares of Boston Scientific worth $394M as of Q2 2026.
- Charles Schwab bought 52,971 Boston Scientific shares in Q2 2026, an estimated $2.88M.
- Boston Scientific made up 0.05% of Charles Schwab's portfolio in Q2 2026, its #286 holding.
- Charles Schwab first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Boston Scientific position peaked at $937M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.